Patient Stakeholder Versus Physician Preferences Regarding Amyloid PET Testing.

ABSTRACT:

Background

Patient and caregiver perspectives on amyloid positron emission tomography (PET) use are largely unexplored, particularly as compared with clinician views.

Methods

We surveyed clinicians, patients, caregivers, and dementia advocates on topics relating to an evidence-based guideline on amyloid PET use. Topic importance was rated on a 9-point scale. Patient stakeholder and clinician views were compared using the Mann-Whitney U test.

Results

Patient representatives (n=107) rated all survey topics as equal to or more important than clinicians (n=114) except 1 item discussing potential harms of false-positive diagnoses. Differences between patient representative and clinician populations were greatest when comparing the competing values of false-positive and fal

SUBMITTER: Armstrong MJ 

PROVIDER: S-EPMC6710130 | biostudies-literature | 2019 Jul-Sep

REPOSITORIES: biostudies-literature